The prion protein: Structural features and related toxic peptides

Area of Science:

• Neuroscience
• Biochemistry
• Structural Biology

Background:

• Prion diseases stem from the misfolding of cellular prion protein (PrP(C)) into pathogenic scrapie forms (PrP(Sc)).
• The exact cellular role of PrP(C) and the molecular basis of PrP(Sc)-induced neurodegeneration remain unclear.
• Limited structural data exists on PrP aggregate formation and its associated toxicity.

Purpose of the Study:

• To review structure-activity relationships of prion protein fragments.
• To investigate the role of specific PrP domains and secondary structures in aggregation and neurotoxicity.
• To understand the structural basis of prion protein misfolding.

Main Methods:

• Analysis of structure-activity studies using prion protein fragments.
• Examination of peptides derived from N-terminal and C-terminal domains of PrP.
• Focus on secondary structure propensity (alpha-helix vs. beta-sheet) and aggregation behavior.

Main Results:

• Most PrP fragments, excluding helices 1 and 3, exhibit high beta-sheet propensity and aggregate readily.
• Helix 2 is critical, capable of adopting both misfolded and helical conformations.
• Only specific mutants demonstrate significant intrinsic neurotoxicity.

Conclusions:

• Prion protein fragment studies highlight the propensity for beta-sheet formation and aggregation.
• Helix 2's conformational flexibility is key in prion protein misfolding.
• Targeted mutations are necessary to induce significant neurotoxicity, suggesting complex pathogenic mechanisms.